Circulating microRNA profile predicts disease progression in patients receiving second-line treatment of lapatinib and capecitabine for metastatic pancreatic cancer

Category Primary study
JournalOncology Letters
Year 2016
This article has no abstract
Epistemonikos ID: 532f41b8a5edf1dbbc8f978f302f3f87a8dc0479
First added on: Feb 07, 2025